Qyuns Therapeutics Co., Ltd. Class H had a revenue of 56.94M in the quarter ending Dec 31, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 158.79M, Decreased 42.32%. In the fiscal year ending Dec 31, 2024, Qyuns Therapeutics Co., Ltd. Class H had annual revenue of 158.79M with 976.49% growth.